MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,494,000 | +7.3% | 130,705 | +2.2% | 0.39% | +10.9% |
| Q2 2022 | $2,325,000 | -28.7% | 127,949 | -1.1% | 0.35% | -14.3% |
| Q1 2022 | $3,262,000 | -10.5% | 129,435 | -2.0% | 0.41% | -12.5% |
| Q4 2021 | $3,646,000 | -16.5% | 132,101 | -2.3% | 0.46% | -15.9% |
| Q3 2021 | $4,368,000 | +32.6% | 135,267 | +25.6% | 0.55% | +33.0% |
| Q2 2021 | $3,293,000 | +109666.7% | 107,699 | +89649.2% | 0.42% | – |
| Q4 2018 | $3,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |